Segment Information (Tables)

3 Months Ended

Mar. 31, 2013

Segment Information [Abstract]

Segment Financial Information

The following tables present operating group financial information for the periods indicated:

	Three Months Ended March 31, 2013
	Healthcare		DNA			Total
Net sales:
Software and other	$	17,825	$	5,746		$	23,571
Professional Services		8,055		4,068			12,123
Maintenance and EDI		27,358		582			27,940
Total net sales	$	53,238	$	10,396		$	63,634
Expenses		44,151		10,564			54,715
Segment income (loss)	$	9,087	$	(168	)		8,919
Net corporate/other expenses (1)							12,397
Loss before income taxes						$	(3,478	)
	Three Months Ended March 31, 2012
	Healthcare		DNA			Total
Net sales:
Software and other	$	19,100	$	3,657		$	22,757
Professional Services		5,899		3,541			9,440
Maintenance and EDI		28,316		465			28,781
Total net sales	$	53,315	$	7,663		$	60,978
Expenses		44,129		7,058			51,187
Segment income (loss)	$	9,186	$	605			9,791
Net corporate/other expenses (1)							12,049
Loss before income taxes						$	(2,258	)
(1) Net corporate/other expenses include public company costs, corporate administration expenses, amortization expense which is not attributable to business segments, acquisition-related expenses and net interest expense.

	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Three Months Ended March 31, 2013	$	3,401	$	1,046	$	16		$	4,463
Restructuring and Other One Time Charges
Three Months Ended March 31, 2013	$	1,229	$	-	$	-		$	1,229
Assets as of March 31, 2013	$	412,913	$	39,588	$	(11,602	)	$	440,899
	Healthcare		DNA		Corporate/ Other			Consolidated
Depreciation and amortization
Three Months Ended March 31, 2012	$	3,831	$	844	$	11		$	4,686
Restructuring and Other One Time Charges
Three Months Ended March 31, 2012	$	-	$	-	$	-		$	-
Assets as of December 31, 2012	$	412,841	$	33,207	$	(9,195	)	$	436,853